|
Real-time Estimate
Cboe BZX
03:07:51 2026-10-01 pm EDT
|
5-day change | 1st Jan Change | ||
| 411.25 USD | -2.43% |
|
+1.35% | +25.72% |
| Sep. 30 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| Sep. 28 | Scotiabank Raises Amgen Price Target to $500 From $450, Sector Outperform Rating Kept | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMGEN INC. | Other Pharmaceuticals | -2.37% | +1.35% | +25.72% | +37.86% | +92.37% | 228B |  | |  |
- Stock Market
- Stocks
- AMGN Stock
- Charts Amgen Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
